跳至主要内容
临床试验/NCT06338956
NCT06338956已完成不适用

Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 135,877 人开始时间: 2024年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
135,877
试验地点
1
主要终点
MACCE

研究概览

简要总结

For the management of low-density lipoprotein-cholesterol (LDL-C), some guidelines recommend initial statin treatment with high-intensity statins to achieve at least a 50% reduction in LDL-C levels. High-intensity or maximally tolerated intensity can be maintained without a target goal. However, the European guideline recommends less than 55 mg/dL of LDL-C after PCI.

详细描述

To investigate the Optimal Attained LDL-C Levels in Patients Who Achieved ≥50% LDL-C Reduction After PCI.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients receiving PCI with health check up before and after PCI within 3 years

排除标准

  • Patients receiving statin before PCI
  • Patients with liver cirrhosis
  • Patients with cancer
  • Patients without prescription of statin
  • Patients with LDL-C <55 mg/dL before PCI

研究组 & 干预措施

>=50% LDL-C reduction

LDL-C reduction >=50%

Further divided by LDL <55mg/dL 55< LDL < 70 mg/dL LDL > 70 mg/dL

干预措施: LDL reduction therapy (Drug)

<50% LDL-C reduction

LDL-C reduction <50%

干预措施: LDL reduction therapy (Drug)

结局指标

主要结局

MACCE

时间窗: 10 years after PCI

major adverse cardiac and cerebrovascular events

次要结局

  • Cardiovascular death(10 years after PCI)
  • Repeat revascularization(10 years after PCI)
  • Spontaneous myocardial infarction(10 years after PCI)
  • Ischemic stroke(10 years after PCI)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ki Hong Choi

Professor

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验